General
Preferred name
ARGATROBAN
Synonyms
MCI-9038 ()
MD-805 ()
Argipidine ()
ARGATROBAN ANHYDROUS ()
(3R/S)Argatroban H2O ()
Argatroban (monohydrate) ()
MD-805 (monohydrate) ()
MCI-9038 (monohydrate) ()
Argipidine (monohydrate) ()
Argatroban hydrate, Argipidine,MCI-9038 Monohydrate ()
(2R,4R)-4-methyl-1-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-2-piperidinecarb ()
Argatroban (MCI-9038) ()
Argatroban Monohydrate ()
GN-1600 ()
Argatroban monohydrate ()
Argatroban In Sodium Chloride ()
Gn1600 ()
Acova ()
Novastan ()
DK-7419 ()
Argatroban hydrate ()
Argatroban in dextrose ()
Argatroban-d3 (hydrochloride) ()
P&D ID
PD003142
CAS
74863-84-6
141396-28-3
121785-71-5
1356847-56-7
Tags
available
drug
Approved by
FDA
First approval
2000
Drug indication
Recurrent thrombophlebitis
Thrombosis
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Argatroban (monohydrate) (MD-805 (monohydrate)) is a direct, selective thrombin inhibitor.
PRICE
45
DESCRIPTION
Prescription is by the INN argatroban as there are no brand names. The INN-assigned compound consists of two epimers, and the version we show here matches the structure and stereochemistry in the INN document but does not specify the epimer. One of the epimers is listed on PubChem as CID 152951.
(GtoPdb)
PHARMACODYNAMICS
Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine indicated as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban does not require the co-factor antithrombin III for antithrombotic activity. Argatroban exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; protein C; and platelet aggregation. Argatroban is highly selective for thrombin with an inhibitory constant (Ki) of 0.04 µM. At therapeutic concentrations, Argatroban has little or no effect on related serine proteases (trypsin, factor Xa, plasmin, and kallikrein).; Argatroban is capable of inhibiting the action of both free and clot-associated thrombin.
DESCRIPTION
Argatroban (MD-805) is a direct, selective thrombin inhibitor.
PRICE
54
DESCRIPTION
Argatroban is a synthetic direct thrombin inhibitor.
(Enamine Bioactive Compounds)
DESCRIPTION
Argatroban Monohydrate is a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Mitochondrial hexokinase inhibitor
(Tocris Bioactive Compound Library)
DESCRIPTION
Potent thrombin inhibitor
(Tocriscreen Plus)
DESCRIPTION
Argatroban (MCI-9038), a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
31
AdooQ Bioactive Compound Library
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
57
Molecular Weight
508.25
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
6
Rotatable Bonds
9
Ring Count
3
Aromatic Ring Count
1
cLogP
0.91
TPSA
177.71
Fraction CSP3
0.61
Chiral centers
4.0
Largest ring
6.0
QED
0.16
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Thrombin inhibitor
Inhibitor
Inhibitors of Blood Coagulation Pathways
thrombin inhibitors
Target Type
Enzymes
Target
Thrombin
Primary Target
Other Proteases
Member status
member
Therapeutic Class
Anticoagulants
Pathway
Metabolic Enzyme/Protease
Proteases/Proteasome
Source data

